Concord Medical Services
4 hedge funds and large institutions have $84.3K invested in Concord Medical Services in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and 0 closing their positions.
33% more funds holding
Funds holding: 3 → 4 (+1)
0% less ownership
Funds ownership: 0.01% → 0.01% (-0%)
22% less capital invested
Capital invested by funds: $108K → $84.3K (-$23.4K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$134 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$17.1K |
CCM Hedge Fund Activity: Q3 2023 in Review
4 of the 6,309 institutional investors tracked by Wall St. Rank reported a position in Concord Medical Services (CCM) for Q3 2023, worth a combined $84.3K — down 22% from $108K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new CCM positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.
The largest buyer was UBS Group, opening a new position worth an estimated $134. The largest seller was Renaissance Technologies, cutting an estimated $17.1K.
- 4 institutional investors held Concord Medical Services (CCM) as of Q3 2023, up from 3 in Q2 2023.
- Funds reported $84.3K of Concord Medical Services stock for Q3 2023, down 22% quarter-over-quarter.
- 1 fund opened new Concord Medical Services positions in Q3 2023 and 0 closed out, a net change of +1 holder.
- The largest Concord Medical Services buyer in Q3 2023 was UBS Group, an estimated $134 added.
- The largest Concord Medical Services seller in Q3 2023 was Renaissance Technologies, an estimated $17.1K sold.
Based on aggregated 13F filings for Q3 2023.